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ABSTRACT Single sarcoplasmic reticulum (SR) Ca2" release channels were reconstituted from normal and malignant hyperthermic
(MH) human skeletal muscle biopsies (2-5-g samples). Conduction, gating properties, and myoplasmic Ca2+ dependence of
human SR Ca2+ release channels were similar to those in other species (rabbit, pig). The MH diagnostic procedure distinguishes
three phenotypes (normal, MH-equivocal, and MH-susceptible) on the basis of muscle contracture sensitivity to caffeine and/or
halothane. Single channel studies reveal that human MH muscles (both MH phenotypes) contain SR Ca2+ release channels with
abnormally greater caffeine sensitivity. Muscles from MH-equivocal and MH-susceptible patients appear to contain channels with
the same abnormality. Further, our data (n = 1 15, 21 channels, 1 1 patients) reveals that human MH muscles (both phenotypes)
may contain two populations of SR Ca2+ release channels, possibly corresponding to normal and abnormal isoforms. Thus, whole
cell phenotypic variation (MH-equivocal vs. MH-susceptible) arises in muscles containing channels with similar caffeine sensitivity
suggesting that human MH does not arise from a single defect. These results have important ramifications concerning (a)
correlation of functional and genetic MH studies, (b) identification of other, yet to be determined, factors which may influence MH
expression, and (c) characterization of normal SR Ca2+ release channel function by exploring genetic channel defects.
INTRODUCTION
Malignant hyperthermia is an inherited skeletal muscle
disorder triggered by commonly used anesthetic agents.
It can be lethal unless immediately recognized and
treated (1-3). The MH syndrome is characterized by
accelerated metabolism, skeletal muscle rigidity, and
rapidly rising body temperature. The frequency ofMH is
- 1 in 100,000 adult anesthetic procedures (1 in 15,000
for children). An abnormality in the regulation of the SR
Ca2" release mechanism is thought to be involved in MH
pathogenesis (4-8). Recent molecular genetic studies
suggest that human MH mutations are located in the
gene that codes for the ryanodine receptor (RyR)
protein (9, 10), the putative SR Ca2" release channel.
Identification of the rabbit RyR as the SR Ca2" release
channel (11), sequencing of the RyR protein (12, 13),
and putative localization of human MH mutations in the
RyR gene (9) provide a stimulating prelude to our study
in which we identify functional defects in the human MH
Ca2+ release (RyR) channel.
We show that conductance, gating properties, and
myoplasmic Ca2' dependence of normal and MH human
SR Ca2+ release channels are similar to rabbit and
normal pig channels. A recent study using a porcine
model of MH reported that MH pig SR Ca2+ release
channels have abnormal myoplasmic Ca2+ dependence
(14). In this study, we demonstrate that human MH
muscles contain SR Ca2' release channels with abnor-
mal caffeine sensitivity. Comparison of molecular (single
channel) and whole cell (contracture) data indicate that
(a) two MH phenotypes (distinguished by caffeine/
halothane contracture sensitivity) arise in muscles con-
taining channels with similar caffeine sensitivity and (b)
human MH muscles (both phenotypes) contain two
populations of SR Ca2" release channels, possibly nor-
mal and abnormal isoforms. Defining functional abnor-
malities in human MH muscle is a necessary step in the
identification of genes containing human MH muta-
tions.
MATERIALS AND METHODS
Heavy SR membrane fractions were prepared as previously described
(15-17). Excess human tissue from vastus lateralis biopsies from
consenting MH diagnostic patients was used. Human (and animal)
protocols and procedures were approved by the appropriate institu-
tional review boards. Heavy SR membranes were stored at -85°C until
used in bilayer experiments.
Human vastus lateralis biopsies were performed as part of the MH
diagnostic procedure (MH Diagnostic Center, Department of Anesthe-
siology, University of Texas, Health Science Center, Houston, TX).
Individual skeletal muscle fascicles (average: 78 mg and 15 mm long)
were isolated and secured in a temperature controlled (37°C) tension
monitoring apparatus. The diagnostic test was based on criterion
established by the North American MH Diagnostic Group (18) and by
our laboratory (19). These tests distinguish three phenotypes: Normal,
MH-equivocal (MHE), and MH-susceptible (MHS). The diagnostic
criterion are described below. Normal human skeletal muscle fascicles
generate 1.0 g of tension at caffeine concentrations equal to or > 4.0
mM and generate < 0.7 g of tension in the presence of 3% halothane.
MHS muscles generate 1.0 g at caffeine concentrations <4.0 mM
and/or have abnormal contracture ( > 1.0 g) triggered by 3% halothane.
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The MHE diagnosis is based on another contracture test, i.e., caffeine
contracture sensitivity in the presence of 1% halothane. MHE muscle
responds normally to caffeine in the absence of halothane and
normally to 3% halothane. In the presence of 1% halothane, MHE
muscle generates 1.0 g of tension at caffeine concentrations < 0.8 mM.
Bilayer experiments were performed as described in detail else-
where (20). Briefly, planar lipid bilayers were formed by the Mueller-
Rudin technique across a 250-,um diam aperture. Bilayer forming
solution contained a 7:3 miture (50 mg/ml in decane) of palmitoyl-
oleoyl-phosphatidylethanolamine and palmitoyl-oleoyl-phosphatidyl-
choline. Lipids were obtained from Avanti Polar lipids (Pelham, AL).
Salt-agar Ag/AgCl2 electrodes were used. Membranes (3-20 mg/ml)
were applied directly to one side of the bilayer (defined as cis, other
side defined as trans). Fusion and recording were performed (unless
specified) in standard solutions containing 250 mM cis Cs-CH3SO4 (50
mM trans), 10 mM Cs-Hepes (pH 7.4), pCa 5. After SR membrane
fusion, bilayers remained stable at 0 mV for up to 1.5 h. Membrane
potentials are referenced to trans. Polarization (50-100 mV) of the
bilayer significantly decreased bilayer lifetime ( < 30 min). Thus, single
channel data were sampled at positive potentials (50-100 mV) during
short (100-500 ms) repetitive (0.5-0.05 Hz) steps from 0 mV. Rou-
tinely, single channel activity (e.g., open probability) was assessed
under each experimental condition from at least 64 voltage steps
(corresponding to roughly 10,000 open events under control condi-
tions). Most single channel data were analyzed using automated single
channel detection. When necessary, detection threshold was set at
50% of the average channel amplitude determined from total ampli-
tude histograms (21). Approximately 60% of channel incorporations
involved multiple channels. Bilayers which contained more than two
channels were immediately reformed. Bilayers containing channels
displayed time-dependent changes in open probability (Po) were also
discarded (-5% of reconstituted channels). Po experiments were
performed only on bilayers which contained a single channel. Some
conduction, pharmacology, and survey experiments (those not involv-
ing Po determinations) were performed on bilayers which contained
two channels. The bilayer pulsing technique (a) provided a reliable
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automated sampling protocol, (b) allowed reproducible and consistent
measurements of single channel properties, and (c) extended the
experimental lifetime of the bilayer.
Data acquisition software and hardware (pClamp, Tl-1 interface;
Axon Instruments, Burlingame, CA) were computer interfaced. Data
were digitized at 5-10 kHz, filtered at 3-4 kHz, and stored on floppy
disk. Analysis software was provided by Dr. T. VanDongen and Dr. A.
Brown (Baylor College of Medicine, Houston, TX) and supplemented
by commercial programs (pClamp; Axon Instruments).
RESULTS AND DISCUSSION
In this study, we present a methodology to reconstitute
the SR Ca2" release channel in planar bilayers from
small samples (2-5 g) of human biopsied skeletal mus-
cle. This method is based on the observation that
purified rabbit RyR channel mediates a fast gating, large
monovalent conductance (11). Since cesium virtually
blocks the conductance of other SR cation channels (22)
and is highly conductive through the RyR channel (11),
cesium was used to isolate the conductance of single
human SR Ca2' release channels. The cesium conduct-
ing human SR Ca2' release channel was pharmacologi-
cally identified by its ryanodine, ruthenium red, Ca2+,
and caffeine sensitivity.
Conduction and gating properties of normal human,
rabbit, and pig SR Ca2' release channels are illustrated
in Fig. 1. Pig channels were included in the interspecies
comparison since MH has been extensively studied using
porcine MH models (4-7, 14). Single channel records
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FIGURE 1 Interspecies comparison of single SR Ca2" release channels. Channels (conducting cesium) were pharmacologically identified as the
RyR. (A) Single channel records (opening upward, baseline marked) from rabbit, pig, and human skeletal muscle. Channels from all three species
have similar gating characteristics. Solutions contained: 250 mM Cs-CH3SO4 symmetrical, 10 mM Cs-Hepes (pH 7.4), pCa 5. The holding potential
was + 80 mV. (B) Current/voltage relationships from rabbit (open circles), pig (open triangles), and human (solid circles) under same conditions. The
cesium slope conductance is 470 pS. Filled diamonds depict conductance after an ionic exchange (50 mM Ba2+ for 250 mM Cs' trans with removal
of all cis Cs+). The shift in reversal potential indicates an estimated PBa/PCs of 7.8.
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(Fig. 1 A) were collected at +80 mV under identical
ionic conditions (symmetrical 250 mM Cs-CH3SO4).
Single channel open events are shown as upward deflec-
tions from the baseline (marked). The channel gating in
all three species was well described by two open and two
closed states (see human data, Table 1). The current/
voltage relationships for rabbit (open circles), pig (open
triangles), and human (filled circles) SR Ca2' release
channels are shown in Fig. 1 B. Data from all three
species were well described by slope conductance of 479
pS. A reversal potential shift due to addition of barium
(50 mM trans, filled diamonds) reveal that the Cs+
conducting channels were divalent selective (PBa/PCs
estimate 7.8). Channel gating, divalent slectivity, and
slope conductance of rabbit, pig, and human SR Ca2+
release channel were nearly indistinguishable.
A generally supported hypothesis is that MH arises
from a defect in regulation of myoplasmic Ca2+ concen-
tration, probably involving the SR Ca2+ release mecha-
nism (4-8). A recent study has demonstrated in a
porcine model that MH muscles do contain abnormal
SR Ca2+ release channels (14). Thus, our investigation of
human SR Ca2+ release channels began by examining
some fundamental properties of normal and MH-
susceptible (MHS) channels including, conductance,
stationary Po, channel gating, and the action of ryano-
dine. In the standard solution (see Methods) normal and
MH channels did not have significantly different conduc-
tance (Fig. 2A, Table 1) or average Po (Table 1).
Further, the gating of MHS and MHE channels (two
open and two closed states) correspond well to the
averages of normal human channels (Table 1). The
action of 2 ,uM ryanodine on normal and MH human
release channels was also very similar. The effect of
ryanodine on a human channel from a MH patient is
illustrated in Fig. 2 B. Ryanodine dramatically increased
TABLE 1 Values are means and standard deviations
Normal MHE MHS
Po 0.084 ± 0.056 (11/5) 0.098 ± 0.081 (9/3) 0.066 ± 0.043 (9/4)
gCs 480.6 ± 24.1 (11/4) 471.3 + 27.6 (7/3) 467.2 ± 39.9 (8/4)
TOl 0.153 + 0.082 (3/3) 0.216 ± 0.109 (3/3) 0.241 ± 0.138 (3/3)
To2 3.101 ± 0.624 (3/3) 4.394 ± 0.865 (3/3) 2.615 t 0.932 (3/3)
Tc1 0.453 t 0.191 (3/3) 0.330 ± 0.129 (3/3) 0.474 ± 0.207 (3/3)
Tc2 30.76 ± 8.37 (3/3) 32.77 ± 9.157 (3/3) 33.01 ± 8.34 (3/3)
Number of determinations (in parenthesis) are number of channels
over number of patients. Po = open probability, gCs = cesium
conductance in standard solution. Tol and To2 are the two open time
constants. Tc1 and Tc2 are the closed time constants. Time constant
values were generated by fitting log (8 bin/decade) open and closed
time histograms. Under control conditions (pCa 5), there were not
significant (T test;p values > 0.05) differences in conduction or gating
of normal, MHE, and MHS channels.
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FIGURE 2. Comparison of human SR Ca2' release channels from
normal and MHS muscle. (A ) Current/voltage relationships. Under
control conditions, normal (open circles) and MHS (solid circles)
channels had a slope conductance of 488 and 479 pS, respectively.
Addition of 2 FM ryanodine to the same channels (normal = open
triangles, MHS = solid triangles) decreased conductance to 255 and
268 pS, respectively. (B) Single channel records (holding potential 40
mV) from the same MHS patient demonstrating the action of
ryanodine on channel gating. Ryanodine dramatically increased single
channel Po while decreasing single channel conductance. Baselines
(zero current levels) are marked at left. (C) Calcium dependence of
single channel activity. The free myoplasmic (cis) [Ca2+] was titrated by
adjusting the Ca/EGTA ratio. Normal human (solid symbols) and MHS
human (open symbols) channels had very similar calcium dependence.
Each point represents mean (+S.E.) of data from two to six channels
from two normal and three MHS diagnostic patients.
Po (- 0.1-0.8) and stabilized the channel in a subconduc-
tance state. The ryanodine-modified conductances of
normal, MHE, and MHS human channels were not
significantly different (Fig. 2A). This dual action of
ryanodine (increase Po, stabilized subconductance) is
identical to that described for the purified and native
channels from rabbit muscle (11).
A single channel study on a porcine MH model
demonstrated that SR Ca2' release channels from MH
muscles have abnormal myoplasmic Ca2' dependence
(14). Thus, we searched for a similar abnormality in
human MH muscles. The myoplasmic Ca2+ dependence
Fill et al. Human Skeletal Muscle Ca2. Release Channels 1087
8 7 6 5 4 3
CALCIUM CONCENTRATION (pCa)
Fill et al. Skeletal Muscle Ca" Release Channels 1087
of normal (filled circles) and MHS (open circles) human
SR Ca2" release channels are nearly identical (Fig. 2 C).
Single channel open probability is normalized to control
Po measured in the standard solution at the beginning of
each tritation. These experiments on human channels
correspond directly to the experiments on MH pig
channels. We believe the apparent lack of a Ca2+
regulatory defect in MHS human channels may reflect
subtle but important genetic differences between MH in
pig and human. It is also important to note that our
human experiments and the pig experiments (14) de-
scribe the steady state action of Ca2+ on channel activity.
These experiments do not address the possibility that
the time course of Ca2' activation or inactivation are
abnormal in MH channels.
The human MH diagnosis is, in part, based on
abnormal contracture response to caffeine (see Meth-
ods). Because caffeine is a potent modulator of the SR
Ca2' release channel, we explored the caffeine sensitivity
of human MH channels. The MH diagnostic contracture
test distinguishes three phenotypes, normal (N), MH-
equivocal (MHE), and MH-susceptible (MHS). Human
skeletal muscle biopsies were divided into two portions,
one portion was used for a diagnostic contracture test,
the other was used to prepare microsomes for single
channel experiments. Thus, contracture and single chan-
nel data were obtained from each individual biopsy.
Sample diagnostic contracture data from normal, MHE,
and MHS patients are shown in Fig. 3. Two contraction
phenomena are monitored in the contracture test, isomet-
ric tension and twitch (stimulated at 0.1 Hz). The basal
isometric tension is the diagnostically important param-
eter. Caffeine contracture threshold (CCT), indicated by
the initial rise in basal isometric tension, was 8.0 mM in
the normal human muscle (Fig. 3 A). The CCT was 4.0
and 1.0 mM for the MHE and MHS muscles (Fig. 3, B
and C), respectively. The halothane contracture data is
included to illustrate further differences between the
three phenotypes. Single channel data from the same
three patients (N, MHE, and MHS) are paired with the
corresponding contracture data. The normal human SR
Ca2' release channel (Fig. 3A) was not significantly
activated by 1 mM caffeine. Single channels from the
MHE and MHS patient (Fig. 3,1B and C), however,
were significantly activated by 1 mM caffeine. At the
single channel level, channels from MHE and MHS
patients appear to be abnormally sensitive to caffeine.
This study includes data collected on 11 diagnostic
patients (3 normal, 4 MHE, and 4 MHS). Contracture
data was collected in triplicate. Several channel reconsti-
tution experiments were performed on each patient.
The caffeine-dose dependencies of contracture and
single channel Po are plotted (means + S.E.) in Fig. 4.
At the whole cell level (Fig. 4A), the three phenotypes
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FIGURE 3 Comparison of contracture data and single channel data.
At left, diagnostic contracture data illustrating the contracture re-
sponse to caffeine (dose-dependence) and 3% halothane. Two contrac-
tile phenomena evident, twitch and basal isometric tension. The
diagnostic contracture test is based on isometric tension changes.
Arrow heads indicate application of caffeine (0.5, 1, 2, 4, 8 mM left to
right) and halothane. At right, single channel data (holding potential
40 mV) collected in the standard recording solution (control) and after
the addition of 1 mM caffeine. Open events are upward deflections.
Baselines (zero current levels) marked. (A ) Contracture and single
channel data collected from a normal patient (N-SS1). Threshold
caffeine concentration (in millimolar) are marked. (B) Contracture
and single data collected from a MHE patient (K-MW1). Only the
threshold caffeine concentration is marked. Caffeine additions made
in the same sequence as above. (C) Contracture and single channel
data collected from a MHS patient (H-BT1).
(normal, MHE, and MHS) can clearly be distinguished
by caffeine contracture sensitivity. At the single channel
level (Fig. 4 B), smaller caffeine doses were necessary to
elicit an effect. Single channel data is plotted as percent
change in Po compared with control Po obtained for
each channel during an initial period in the standard
solution. The caffeine sensitivity ofMHE (open triangles)
and MHS channels (open circles) was significantly greater
than that of normal channels (filled circles). Note that
the MHE and MHS phenotypes cannot be distinguished
at the single channel level on the basis of caffeine
sensitivity. This indicates that the phenotypic variation
in caffeine contracture sensitivity (Fig. 4A, MHE and
MHS curves) arises in muscles containing SR Ca2"
release channels with comparable caffeine sensitivity
(Fig. 4 B, MHE and MHS curves). This observation
leads to the suggestion that other, yet to be identified,
factors or abnormalities may influence phenotypic expres-
sion of MH in humans.
The relatively low frequency (occurrence) ofMH and
its complex inheritance pattern suggests that MH pa-
tients are probably heterozygous for MH mutations (10).
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FIGURE 4 Comparison of caffeine dose dependencies at whole cell
(contracture) and molecular (single channel) levels. Data compiled
from 11 diagnostic patients (3 normal, 4 MHE, and 4 MHS). Data
points represent mean (+S.E.) of 4-9 determinations. (A) Caffeine
dose dependency of peak isometric contracture height. Normal (open
circles), MHE (open triangles), and MHS (open circles) muscles were
clearly distinguishable by caffeine sensitivity. (B) Caffeine dose depen-
dency of single channel Po (plotted as % change Po relative to an
initial caffeine-free control period). Normal (solid circles) channels
were clearly distinguishable from MHE (open triangles) and MHS
(open circles) channels. Channels from MHE and MHS muscles have
nearly identical caffeine dose dependencies.
Thus, human MH muscles may contain normal and
abnormal (those containing MH mutations) copies of
the gene coding for the SR Ca2" release channel. If true,
then human MH muscles may contain normal and
abnormal isoforms of the SR Ca2" release channel. This
possibility was explored by pooling single channel data
into two sets (Ca2" dependence and caffeine) and
examining how individual determinations were distrib-
uted about the mean. The Ca2" dependence set is shown
in Fig. 5 A. The percent change Po (at all Ca2" concentra-
tions) was monotonically distributed for both normal
and MH channels. The caffeine set is shown in Fig. 5 B.
The percent change Po (at all caffeine concentrations)
was monotonically distributed for normal channels, but
was bimodally distributed for MH channels. The filled
bars (Fig. 5 B, bottom) correspond to the contribution
MHE channels (remaining open portion to MHS chan-
nels). The bimodality is evident for both MHE and MHS
channels and suggests that human MH muscles (both
phenotypes) contain two populations of channels. The
bimodality may arise from the presence of two channel
isoforms (normal or abnormal) or possibly from a single
isoform with variable caffeine sensitivity.
In this study, we present a methodology to study single
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FIGURE 5 Data point scatter about normalized means suggests that
human MH muscles may contain two populations of SR Ca2" release
channel. Smooth curves represent fitted normal distributions (least
squares method). (A) Ca2" dependency data. The mean Po value
normal and MHS channels at each Ca2" concentration was subtracted
from all data points. Data points (all concentrations) were then pooled
and binned. Ca2" dependency data points were monotonically distrib-
uted about their means in both normal and MH muscle. (B) Caffeine
dependency data. Data transformation same as above. Caffeine
dependence data points were monotonically distributed in normal
muscles, but were bimodally distributed in MH muscles. Data from
MHE (solidportion ofbar) and MHS (open portion ofbar) muscles were
combined.
SR Ca2" release channels from human skeletal muscle
biopsies from MH diagnostic patients. This methodol-
ogy is not specialized to study MH and could be applied
to study other human skeletal muscle disorders. In this
study, we identify a human MH defect in the SR Ca2"
release channel, the RyR protein. Our data, therefore, is
consistent with genetic studies suggesting that the RyR
gene may contain mutations associated with the human
MH syndrome (9). Our data also demonstrates that
phenotypic variation (MHS vs. MHE) in caffeine sensi-
tivity arises in muscles containing channels with similar
caffeine sensitivity. This result leads to the provocative
suggestion that MH does not result from a single defect
in the RyR, but may arise from a combination of defects.
Thus, other factors, which have yet to be identified, may
influence phenotypic expression of MH in humans.
Further, single channel caffeine data supports the hypoth-
esis that human MH muscles (both MH phenotypes)
contain normal and abnormal copies of the SR Ca2"
release channel.
Defining functional MH abnormalities at the molecu-
lar (single channel) level will have important ramifica-
tions in the identification of the gene(s) containing MH
mutations(s) and eventually the development of a nonin-
vasive genetically basedMH diagnostic procedure. Addi-
tionally, our understanding of SR Ca2" release channel
Fill et al. Human Skeletal Muscle Ca2. Release Channels 1089Fill et al. Skeletal Cal' Release Channels 1089
function in normal muscle will be significantly advanced
by defining the functional and genetic abnormalities
which underlie MH pathogenesis.
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